State litigation guide · North Carolina

Hernia Mesh (Davol/C.R. Bard) Lawsuit in North Carolina

Time limits apply in North Carolina. Find out if you still qualify.

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

People's Justice Research TeamUpdated June 11, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Statute of limitations — North Carolina

North Carolina General Statute § 1-52(16) provides a 3-year statute of limitations for personal injury product liability with discovery rule application. North Carolina's statute of repose (N.C.G.S. § 1-46.1) bars claims more than 6 years after the last date the product was sold — one of the shorter repose periods in the country. North Carolina is also a pure contributory negligence state — if the plaintiff is even 1% at fault, they cannot recover.

3 years from discovery; 6-year statute of repose from last sale

Filing venue

Where to File in North Carolina

North Carolina hernia mesh plaintiffs enter litigation across four specialized forums: Davol/CR Bard MDL 2846 (S.D. Ohio, Judge Sargus, ~30,000 cases); Covidien Parietex MDL 2511 (S.D. Ohio, Judge Sargus); Atrium C-QUR MDL 2753 (D.N.H.); and Johnson & Johnson/Ethicon cases in the Atlantic County NJ Superior Court mass tort before Judge Porto. North Carolina cases originate in the Middle or Eastern District of NC before JPML transfer to the applicable MDL.

North Carolina imposes a three-year statute of limitations for products liability under N.C. Gen. Stat. § 1-52(16), with the discovery rule applicable. The limitations period runs from the date the plaintiff discovered, or by reasonable diligence should have discovered, the injury and its causal connection to the mesh product. North Carolina also has a ten-year statute of repose for products liability under § 1-46.1, measured from the date of last purchase; however, the discovery rule can still extend recovery for claimants within the repose window.

North Carolina's hernia mesh market is concentrated in Charlotte (Atrium Health, Novant Health), Raleigh-Durham (Duke Health, UNC Health), and Greensboro-Winston-Salem. Duke University Medical Center and UNC Hospitals are major academic mesh implant centers. The state has significant Bard Davol (Composix Kugel, PerFix, Ventralex) and Ethicon (Physiomesh) product distribution, the latter making North Carolina plaintiffs particularly relevant to the Atlantic County NJ mass tort docket.

North Carolina's strong Ethicon Physiomesh exposure — driven by Ethicon's historical market share in the Southeast — means NC plaintiffs should evaluate whether their claims belong in the Atlantic County NJ mass tort rather than any federal MDL. Ethicon cases do not have a federal MDL; the NJ state court consolidation under Judge Porto is the exclusive centralized forum for J&J/Ethicon hernia mesh claims.

North Carolina data

Exposure in North Carolina

North Carolina's 6-year statute of repose is among the shortest in the nation — patients implanted before 2020 with recalled or discontinued mesh face immediate review deadline

6-year repose

Source: N.C.G.S. § 1-46.1

North Carolina bars all recovery if the plaintiff shares any fault — surgical decision-making and patient choice must be carefully framed to avoid contributory fault arguments

Contributory negligence

Source: North Carolina products liability case law

Estimated annual hernia repair surgeries in North Carolina

~25,000

Source: NC State Center for Health Statistics

Medical resources

Clinics & Specialists in North Carolina

UNC Medical Center — UNC Hernia Center, Department of Surgery

Atrium Health — General Surgery, Charlotte campus

FAQ

Frequently Asked Questions

12 QUESTIONS

Hernia mesh litigation is a mass tort action against manufacturers of defective synthetic mesh implants used in hernia repair surgery. The primary defendants are Davol Inc. and C.R. Bard (now part of Becton Dickinson), Ethicon (a subsidiary of Johnson and Johnson), Atrium Medical, and Covidien (now part of Medtronic). These companies manufactured polypropylene and composite mesh devices that have been associated with serious complications including mesh migration, adhesion, infection, chronic pain, and bowel obstruction. Thousands of patients have filed claims in MDL 2846 in the Southern District of Ohio and in state court coordinations.

Keep reading